KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Current Leases (2020 - 2025)

Novavax (NVAX) has 9 years of Current Leases data on record, last reported at $12.4 million in Q4 2025.

  • For Q4 2025, Current Leases fell 27.59% year-over-year to $12.4 million; the TTM value through Dec 2025 reached $12.4 million, down 27.59%, while the annual FY2025 figure was $12.4 million, 27.59% down from the prior year.
  • Current Leases reached $12.4 million in Q4 2025 per NVAX's latest filing, up from $5.0 million in the prior quarter.
  • Across five years, Current Leases topped out at $130.5 million in Q4 2021 and bottomed at $953000.0 in Q2 2023.
  • Average Current Leases over 5 years is $44.2 million, with a median of $11.0 million recorded in 2024.
  • Peak YoY movement for Current Leases: tumbled 99.23% in 2023, then soared 889.19% in 2024.
  • A 5-year view of Current Leases shows it stood at $130.5 million in 2021, then tumbled by 79.17% to $27.2 million in 2022, then tumbled by 81.09% to $5.1 million in 2023, then skyrocketed by 232.61% to $17.1 million in 2024, then decreased by 27.59% to $12.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $12.4 million in Q4 2025, $5.0 million in Q3 2025, and $5.6 million in Q2 2025.